Literature DB >> 9213064

The cerebellum in Alzheimer's disease.

A J Larner1.   

Abstract

The cerebellum is a relatively neglected area of the Alzheimer's disease (AD) brain, probably because it was formerly thought to be spared by the disease. However, a number of pathological changes have now been revealed in the AD cerebellum, principally by immunocytochemical studies, including widespread deposits of diffuse amyloid, ubiquitin-immunoreactive dystrophic neurites, and increased microglia, but tau-immunoreactive neurofibrillary tangles have not been seen. Although the observed changes may be merely epiphenomenal to the pathological processes occurring in the AD neocortex and hippocampus, the morphological and immunocytochemical differences between AD cerebral cortex and cerebellar cortex may nonetheless give insights into the molecular factors involved in the development of the neuropathological lesions of AD brain.

Entities:  

Mesh:

Year:  1997        PMID: 9213064     DOI: 10.1159/000106632

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  43 in total

Review 1.  Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be "extraordinarily diverse".

Authors:  Madhav Thambisetty
Journal:  Am J Physiol Cell Physiol       Date:  2017-06-14       Impact factor: 4.249

2.  Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients.

Authors:  Shuko Takeda; Caitlin Commins; Sarah L DeVos; Chloe K Nobuhara; Susanne Wegmann; Allyson D Roe; Isabel Costantino; Zhanyun Fan; Samantha B Nicholls; Alexis E Sherman; Ana T Trisini Lipsanopoulos; Clemens R Scherzer; George A Carlson; Rose Pitstick; Elaine R Peskind; Murray A Raskind; Ge Li; Thomas J Montine; Matthew P Frosch; Bradley T Hyman
Journal:  Ann Neurol       Date:  2016-08-03       Impact factor: 10.422

3.  Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.

Authors:  Konrad Talbot; Hoau-Yan Wang; Hala Kazi; Li-Ying Han; Kalindi P Bakshi; Andres Stucky; Robert L Fuino; Krista R Kawaguchi; Andrew J Samoyedny; Robert S Wilson; Zoe Arvanitakis; Julie A Schneider; Bryan A Wolf; David A Bennett; John Q Trojanowski; Steven E Arnold
Journal:  J Clin Invest       Date:  2012-04       Impact factor: 14.808

Review 4.  Correlating familial Alzheimer's disease gene mutations with clinical phenotype.

Authors:  Natalie S Ryan; Martin N Rossor
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

5.  Neuropathological and biochemical assessments of an Alzheimer's disease patient treated with the γ-secretase inhibitor semagacestat.

Authors:  Alex E Roher; Chera L Maarouf; Tyler A Kokjohn; Charisse M Whiteside; Walter M Kalback; Geidy Serrano; Christine Belden; Carolyn Liebsack; Sandra A Jacobson; Marwan N Sabbagh; Thomas G Beach
Journal:  Am J Neurodegener Dis       Date:  2014-12-05

6.  Similar Microglial Cell Densities across Brain Structures and Mammalian Species: Implications for Brain Tissue Function.

Authors:  Sandra E Dos Santos; Marcelle Medeiros; Jairo Porfirio; William Tavares; Leila Pessôa; Lea Grinberg; Renata E P Leite; Renata E L Ferretti-Rebustini; Claudia K Suemoto; Wilson Jacob Filho; Stephen C Noctor; Chet C Sherwood; Jon H Kaas; Paul R Manger; Suzana Herculano-Houzel
Journal:  J Neurosci       Date:  2020-04-06       Impact factor: 6.167

7.  Cerebellar Molecular and Cellular Characterization in Rat Models of Alzheimer's Disease: Neuroprotective Mechanisms of Garcinia Biflavonoid Complex.

Authors:  Olayemi Joseph Olajide; Anita Temi Ugbosanmi; Bernard Ufuoma Enaibe; Kehinde Yomi Ogunrinola; Susan Folashade Lewu; Nnaemeka Tobechukwu Asogwa; Tosan Akapa; Aminu Imam; Abdulmumin Ibrahim; Ismail Temitayo Gbadamosi; Emmanuel Olusola Yawson
Journal:  Ann Neurosci       Date:  2017-04-21

Review 8.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

9.  In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease.

Authors:  Victor L Villemagne; Shozo Furumoto; Michelle T Fodero-Tavoletti; Rachel S Mulligan; John Hodges; Ryuichi Harada; Paul Yates; Olivier Piguet; Svetlana Pejoska; Vincent Doré; Kazuhiko Yanai; Colin L Masters; Yukitsuka Kudo; Christopher C Rowe; Nobuyuki Okamura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-11       Impact factor: 9.236

10.  Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease.

Authors:  Emmanuel Planel; Tomohiro Miyasaka; Thomas Launey; De-Hua Chui; Kentaro Tanemura; Shinji Sato; Ohoshi Murayama; Koichi Ishiguro; Yoshitaka Tatebayashi; Akihiko Takashima
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.